Gold Nanoclusters as Nano-Antibiotic Auranofin Analogues

18 May 2021, Version 1
This content is a preprint and has not undergone peer review at the time of posting.


Auranofin, a gold(I)-complex with tetraacetylated thioglucose and triethylphosphine ligands, is an FDA-approved drug used as an anti-inflammatory aid in the treatment of rheumatoid arthritis. In repurposing auranofin for other diseases, it was found that the drug showed significant activity against Gram-positive bacteria but was inactive against Gram-negative bacteria. Herein, we report the design and synthesis of gold nanoclusters (AuNCs) based on the structural motif of auranofin. Phosphine-capped AuNCs were synthesized and glycosylated, yielding auranofin AuNC analogues with mixed phosphine/thioglucose ligand shells. These AuNCs were active against both Gram-negative and Gram-positive bacteria, including a panel of resistant ESKAPE pathogens. Notably, an auranofin analogue, a mixed-ligand 1.6 nm AuNC (4b) was ~4 times more active than auranofin against Pseudomonas aeruginosa, while exhibiting 24 times lower toxicity against human A549 cells. The enhanced antibacterial activity of these AuNCs was characterized by a greater uptake of Au by the bacteria compared to AuI-complexes (20% for AuNC 4b). Additional factors include increased oxidative stress, moderate inhibition of thioredoxin reductase (TrxR), and DNA damage. Most intriguingly, the AuNCs were not affected by the bacterial outer membrane (OM) barrier or by extracellular proteins. This contrasts with AuI-complexes like auranofin that are susceptible to protein binding and hindered by the OM barrier.


Gold nanoclusters
Pseudomonas aeruginosa

Supplementary materials

WN AuClustr SI


Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.